XTLB XTL Biopharmaceuticals ADRs

XTL Biopharmaceuticals Ltd is engaged in the acquisition & development of pharmaceutical drugs for the treatment of unmet medical needs, currently for the treatment of schizophrenia and Hepatitis C. It has also developed a home therapeutic device. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:XTLB.

$3.24
As of 03/02/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
ADRs
Micro cap
Health Care
Biotechnology
Israel
Israel
02/18/2014
5,142,000
25,964
$16,557,240
0.00%
SEC Edgar Online
20-F
98386D307
US98386D3070

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
2.01
0.00
-34.79%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy